Juan Lü

5.6k citations
143 papers · 4.2k · 1 hit paper · h-index 36

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • Circular RNAs in diseases
    • RNA modifications and cancer
    • Epigenetics and DNA Methylation
    • Extracellular vesicles in disease

Papers in

    • RNA modifications and cancer 14
    • Circular RNAs in diseases 13
    • Epigenetics and DNA Methylation 8
    • Cancer-related molecular mechanisms research 30
    • MicroRNA in disease regulation 21

Juan Lü

137 papers receiving 4.2k citations

Juan Lü's Hit Papers

FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson's Disease 2020 · 322 citations
3220+2+4Years since publication100200300

Peers

Juan Lü
Comparison fields: 5 of 123
  • Cancer Research 1.6k
  • Molecular Biology 2.3k
  • Otorhinolaryngology 99
  • Oncology 584
  • Immunology 376
Replace Alexander T.H. Wu with:
Alexander T.H. Wu Taiwan
Yue Zhang China
Shuai Zhang China
Li Zhao China
Sandeep Kumar United States
Xiao‐Feng Zhu China
Diana Gulei Romania
Kwang‐Huei Lin Taiwan
Juan Lü relative to Alexander T.H. Wu Taiwan Alexander T.H. Wu's profile →
Citations per field
00.5×1.7×
Alexander T.H. Wu · 1×
Citations per year

Countries citing papers authored by Juan Lü

Since Specialization
Citations

This map shows the geographic impact of Juan Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Lü more than expected).

Fields of papers citing papers by Juan Lü

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Lü. The network helps show where Juan Lü may publish in the future.

Co-authors

The 25 scholars most cited alongside Juan Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Juan Lü Line = papers co-authored together Juan Lü links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 143 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2011329
2
FTH1 Inhibits Ferroptosis Through Ferritinophagy in the 6-OHDA Model of Parkinson's Disease
Hit paper breakdown →
2020322
3 2018181
4 2021154
5 2022142
6 2011107
7 2010104
8 202299
9 201099
10 201498
11 201386
12 201683
13 201875
14 201370
15 202063
16 200962
17 201362
18 200962
19 201359
20 201256

About Juan Lü

Juan Lü is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 143 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (30 papers), MicroRNA in disease regulation (21 papers), RNA modifications and cancer (14 papers), Circular RNAs in diseases (13 papers), Head and Neck Cancer Studies (10 papers), Epigenetics and DNA Methylation (8 papers), Viral-associated cancers and disorders (8 papers) and Liver physiology and pathology (6 papers). The work is most often cited by research in Cancer Research (1.6k citations), Molecular Biology (2.3k citations), Otorhinolaryngology (99 citations), Oncology (584 citations) and Immunology (376 citations). Juan Lü has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xiong Liu, Xiangping Li, Lanjuan Li, Chen Xue, Ming‐Liang He, Ganglei Li, Ying Peng, Hsiang‐Fu Kung, Lu Wang and Junsong Wang. Their work appears in journals such as Frontiers in Oncology, Biomedicine & Pharmacotherapy, Oncotarget, Investigative Ophthalmology & Visual Science and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact